Sponsor
Oractive Swiss AG
Industriestrasse 47, 6300
About the sponsor
Oractive Swiss AG is involved in research related to alendronate, a treatment used in osteoporosis and other bone resorption disorders, with interest in formulations that support oral administration and therapeutic use in healthy volunteers.
- Bisphosphonate treatment
- Osteoporosis management
- Bone density preservation
The sponsor’s clinical activity reflects attention to skeletal health and the evaluation of established therapies within the musculoskeletal field.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.